Trials / Completed
CompletedNCT00522470
Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels
Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels in Diabetic Women
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Baskent University · Academic / Other
- Sex
- Female
- Age
- 45 Years – 65 Years
- Healthy volunteers
- —
Summary
We aimed to evaluate the effects of rosiglitazone on serum ghrelin and peptide yy levels in diabetic women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rosiglitazone |
Timeline
- First posted
- 2007-08-29
- Last updated
- 2008-05-09
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00522470. Inclusion in this directory is not an endorsement.